Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Howaru is a premium probiotic brand and business unit of IFF (International Flavors & Fragrances), specializing in the development and commercialization of clinically-documented probiotic strains. The company’s portfolio features highly researched strains such as Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019, which are utilized in dietary supplements, functional foods, and beverages. Howaru provides end-to-end solutions, including strain selection, stabilization technology, and finished format manufacturing, to support global health and wellness brands. With a strong emphasis on microbiome science, the company targets a wide range of health areas including digestive, immune, women's, and metabolic health. Following the merger of DuPont Nutrition & Biosciences with IFF, Howaru operates as a core component of IFF's Health Sciences division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Howaru.